These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1520842)

  • 1. From experimental units to unique experiments: chronobiologic pilots complement large trials.
    Halberg F; Cornélissen G; Bingham C; Fujii S; Halberg E
    In Vivo; 1992; 6(4):403-27. PubMed ID: 1520842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power of chronobiologic pilots: a statistician's opinion.
    Berry DA
    Chronobiologia; 1993; 20(3-4):213-8. PubMed ID: 8131670
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials: the larger the better?
    Halberg F; Bingham C; Cornélissen G
    Chronobiologia; 1993; 20(3-4):193-211. PubMed ID: 8131669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the chronotherapeutic index in the experimental animal laboratory.
    Halberg E; Cornélissen G; Halberg F
    In Vivo; 1992; 6(4):371-85. PubMed ID: 1520840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chronotherapy: a drug delivery challenge.
    Hrushesky WJ
    Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical cancer chronotherapy trials: a review.
    Bjarnason GA
    J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronobiologic response modifiers and breast cancer development: classical background and chronobiologic tasks remaining.
    Cornélissen G; Halberg F
    In Vivo; 1992; 6(4):387-402. PubMed ID: 1520841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacology: a therapeutic frontier.
    Halberg F; Kabat HF; Klein P
    Am J Hosp Pharm; 1980 Jan; 37(1):101-6. PubMed ID: 7361768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power of 'phase 0' chronobiologic trials at different signal-to-noise ratios and sample sizes.
    Bingham C; Cornélissen G; Halberg F
    Chronobiologia; 1993; 20(3-4):179-90. PubMed ID: 8131667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hardware and software for (and results from) chronobiologic approaches to cancer treatment and prevention.
    Halberg F
    Chronobiologia; 1986; 13(4):355-8. PubMed ID: 3816409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronochemotherapy for cancer].
    Akazawa S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
    de Lemos ML; Taylor SC; Barnett JB; Hu F; Levin A; Moravan V; O'Reilly SE
    J Oncol Pharm Pract; 2006 Dec; 12(4):193-9. PubMed ID: 17156591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic circadian system patients under chimiotherapy].
    Beau J; Iurisci I; Beau T; Lévi F
    Pathol Biol (Paris); 2007; 55(3-4):171-5. PubMed ID: 17412521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronobiologic lead study cost-effectively assesses circadian-circaseptan intermodulation in murine pineal melatonin content.
    Sánchez de la Peña S; Brown GM; Ungar F; Marques N; Scheving LE; Grota LJ; Halberg F
    Chronobiologia; 1986; 13(4):329-33. PubMed ID: 3816405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapeutics: the relevance of timing in cancer therapy.
    Lévi F
    Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
    Lévi F
    Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian cancer pharmacodynamics.
    Hrushesky WJ
    Ann Ist Super Sanita; 1993; 29(4):705-10. PubMed ID: 7985931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent effects of ASA administration on blood pressure in healthy subjects.
    Hermida RC; Fernández JR; Ayala DE; Iglesias M; Halberg F
    Chronobiologia; 1994; 21(3-4):201-13. PubMed ID: 7729237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.
    Willan A; Kowgier M
    Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
    Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
    J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.